» Articles » PMID: 6184440

Identification of an Idiotypic Marker of a Major Regulatory T Cell of the Immune Response in B10.BR Mice to Ferredoxin. The Relationship of Idiotypic Regulation to Conventional Hapten-carrier Effects

Overview
Journal J Exp Med
Date 1983 Jan 1
PMID 6184440
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

An anti-idiotypic antiserum was raised in rabbits to a monoclonal antibody (Fd-1) with specificity for one (the N epitope) of the two antigenic epitopes found on the ferredoxin (Fd) molecule. The anti-idiotypic antiserum (anti-Fd-1) was used to demonstrate that the Fd-1 idiotype was expressed at significant levels in most anti-Fd antisera raised in B10.BR mice. Examination of antisera raised in other mouse strains demonstrated that expression of this idiotype mapped to the IgH gene complex and was found in the antisera of all mouse strains examined with the Ig-1 allotype. When splenocytes from Fd-immune B10.Br mice were treated with anti-Fd-1 and transferred to irradiated syngeneic recipients, the adoptive secondary response was significantly higher in animals receiving treated cells as opposed to control animals, which received normal rabbit serum-treated cells. This response produced a net increase in antibody to both determinants, and the relative amount of Fd-1 idiotype was not significantly altered. Further studies with separated cell populations showed that the overall increase of anti-Fd antibody produced was attributable to the effects of the anti-idiotypic serum on a population(s) of T cells. Treatment of mice with the Fd-1 monoclonal antibody (which should react with anti-idiotypic cells) had an analogous effect to that of the anti-idiotype, in that mice so treated produced higher concentrations of anti-Fd antibodies when they were immunized and these antibodies exhibited net increases to both determinants. A model is presented to explain these results.

Citing Articles

Modulation of immune response to Lol p I by pretreatment with anti-idiotypic antibody is not restricted to the idiotypic expression.

Boutin Y, Hebert J Clin Exp Immunol. 1994; 96(2):350-5.

PMID: 7514517 PMC: 1534898. DOI: 10.1111/j.1365-2249.1994.tb06566.x.


Evidence for the presence of idiotype-bearing regulatory T cells in which idiotype expression does not show linkage to either IgH alleles or the MHC.

Singhai R, Weaver M, Sikora L, LEVY J Immunology. 1984; 51(4):743-54.

PMID: 6423526 PMC: 1454553.


Immune suppression genes.

Oliveira D, Mitchison N Clin Exp Immunol. 1989; 75(2):167-77.

PMID: 2467772 PMC: 1542112.


New aspects of vaccine development.

Liew F Clin Exp Immunol. 1985; 62(2):225-41.

PMID: 2417761 PMC: 1577440.

References
1.
Willims Jr R, KUNKEL H, Capra J . Antigenic specificities related to the cold agglutinin activity of gamma M globulins. Science. 1968; 161(3839):379-81. DOI: 10.1126/science.161.3839.379. View

2.
Kelly B, LEVY J . Immunological studies on the major haptenic peptides from performic acid oxidized ferredoxin from Clostridium pasteurianum. Biochemistry. 1971; 10(10):1763-6. DOI: 10.1021/bi00786a005. View

3.
Kelly B, LEVY J, Hull D . Cellular and humoral immune responses in guinea pigs and rabbits to chemically defined synthetic peptides. Eur J Immunol. 1973; 3(9):574-9. DOI: 10.1002/eji.1830030910. View

4.
Lozner E, Sachs D, Shearer G . Genetic control of the immune response to staphylococcal nuclease. I. Ir-Nase: control of the antibody response to nuclease by the Ir region of the mouse H-2 complex. J Exp Med. 1974; 139(5):1204-14. PMC: 2139661. DOI: 10.1084/jem.139.5.1204. View

5.
Jerne N . Towards a network theory of the immune system. Ann Immunol (Paris). 1974; 125C(1-2):373-89. View